Our Shareholder Advocacy program partners with investors to promote corporate responsibility regarding all aspects of reproductive and maternal health.
The investors that we work with at Rhia Ventures are committed to leveraging their investment portfolios to effect positive social outcomes. Together, we engage directly with companies in dialogue; attend shareholder meetings; file shareholder proposals; and provide thought leadership through our research, fact sheets, reports and other publications.
In 2020, Rhia Ventures released Hidden Value: The Business Case for Reproductive Health, a groundbreaking report that connects how access to comprehensive reproductive health care impacts a company’s bottom line and the corporate workforce. Prepared in partnership with FSG, the report identifies five major factors that argue for making access to reproductive health care a business imperative. Read more here.
The COVID-19 pandemic is undermining access to time-sensitive and essential reproductive healthcare needs. Read here what companies can do to ensure that their employees get the reproductive healthcare they need during this crisis.
For more information, contact Shelley Alpern, Director of Shareholder Advocacy, at